Profile for Dynavax Technologies Corporation (DVAX)

$ 9.36   0.17 (+1.85%) Volume: 4.43m 4:00 PM EDT 15-Jul-2020
After Hours:  $ 9.35   -0.01 (-0.11%) Volume: 55.46k 7:55 PM EDT 15-Jul-2020
Business Description:
Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor ("TLR") stimulation.
Address: 2100 Powell Street, Suite 900, Emeryville, CA, USA, 94608
Telephone: +1 510 848-5100 Website:
Facsimile: +1 510 848-1327 Email: [email protected]
CEO: Ryan Spencer
Employees: 231 Market Cap: 1.02b
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1029142
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)